机译:具有Polatuzumab Vedotin,Rituximab和Bendamustine在侵袭性B细胞淋巴瘤中的结合的现实生活经验
Natl &
Kapodistrian Univ Athens Laikon Gen Hosp Haematol Clin Trial Unit Propaedeut Dept;
Natl &
Kapodistrian Univ Athens Univ Gen Hosp Attikon Dept Internal Med 2 Propaedeut Hematol;
Papanikolaou Hosp Dept Hematol Thessaloniki Greece;
Theagen Canc Hosp Dept Hematol Thessaloniki Greece;
Aghios Savvas Anticanc Hosp Dept Hematol Athens Greece;
Univ Crete Dept Hematol Iraklion Crete Greece;
Papageorgiou Hosp Hematol Dept Thessaloniki Greece;
Natl &
Kapodistrian Univ Athens Laikon Gen Hosp Dept Haematol &
Bone Marrow Transplantat Athens;
Natl &
Kapodistrian Univ Athens Laikon Gen Hosp Haematol Clin Trial Unit Propaedeut Dept;
Evangelismos Gen Hosp Dept Hematol &
Lymphoma Athens Greece;
Theagen Canc Hosp Dept Hematol Thessaloniki Greece;
Democritus Univ Trace Dept Hematol Alexandroupolis Greece;
Ippokrate Gen Hosp Dept Internal Med 2 Athens Greece;
G Gennimatas Gen Hosp Dept Clin Hematol Athens Greece;
Aristotle Univ Thessaloniki Hippokrat Hosp Dept Med 4 Fac Med Thessaloniki Greece;
Natl &
Kapodistrian Univ Athens Alexandra Hosp Dept Therapeut Athens Greece;
Athens Med Ctr Dept Hematol Athens Greece;
Gen Hosp Kalamata Kalamata Greece;
Univ Ioannina Sch Hlth Sci Dept Hematol Fac Med Ioannina Greece;
424 Army Hosp Dept Hematol Thessaloniki Greece;
Chania Gen Hosp Dept Hematol Khania Greece;
Metropolitan Hosp Dept Hematol Athens Greece;
401 Army Hosp Dept Hematol Athens Greece;
Aristotle Univ Thessaloniki AHEPA Hosp Dept Internal Med 1 Hematol Unit Thessaloniki Greece;
Henry Dunant Hosp Dept Hematol Athens Greece;
Univ Crete Dept Hematol Iraklion Crete Greece;
Aghios Savvas Anticanc Hosp Dept Hematol Athens Greece;
Theagen Canc Hosp Dept Hematol Thessaloniki Greece;
Natl &
Kapodistrian Univ Athens Laikon Gen Hosp Haematol Clin Trial Unit Propaedeut Dept;
Natl &
Kapodistrian Univ Athens Laikon Gen Hosp Dept Haematol &
Bone Marrow Transplantat Athens;
Natl &
Kapodistrian Univ Athens Laikon Gen Hosp Dept Haematol &
Bone Marrow Transplantat Athens;
Natl &
Kapodistrian Univ Athens Univ Gen Hosp Attikon Dept Internal Med 2 Propaedeut Hematol;
Natl &
Kapodistrian Univ Athens Laikon Gen Hosp Dept Haematol &
Bone Marrow Transplantat Athens;
Natl &
Kapodistrian Univ Athens Laikon Gen Hosp Haematol Clin Trial Unit Propaedeut Dept;
Natl &
Kapodistrian Univ Athens Laikon Gen Hosp Dept Haematol &
Bone Marrow Transplantat Athens;
bendamustine; diffuse large Bamp; 8208; cell lymphoma; polatuzumab vedotin; refractory; relapsed; rituximab;
机译:Polatuzumab Vedotin与Bendamustine Plus Rituximab联合用于治疗复发或难治性弥漫性大B细胞淋巴瘤:我们的经验
机译:由Polatuzumab-Vedotin-PIIQ诱导的急性胰腺炎与Bendamustine和Rituximab组合弥漫性大B细胞淋巴瘤
机译:polatuzumab vedotin治疗复发或难治性弥漫性大b细胞淋巴瘤,与bendamustine加里妥昔单抗组合
机译:具有抗利妥昔单抗的B细胞淋巴瘤的有效抗肿瘤活性的利妥昔单抗变体的表征
机译:免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性:RU051417I-R-ICE(利妥昔单抗-异环磷酰胺-卡铂-依托泊苷)与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤(DLBCL)。
机译:多相研究Polatuzumab Vedotin + Bendamustine + Rituximab在复发/难治性弥漫性大B细胞淋巴瘤中
机译:番荔枝蛋白,叶蝉蛋白和衍生大型大B细胞淋巴瘤中的番茄植物和利妥昔单抗的成本效益